Cargando…
On-target restoration of a split T cell-engaging antibody for precision immunotherapy
T cell-engaging immunotherapies are changing the landscape of current cancer care. However, suitable target antigens are scarce, restricting these strategies to very few tumor types. Here, we report on a T cell-engaging antibody derivative that comes in two complementary halves and addresses antigen...
Autores principales: | Banaszek, Agnes, Bumm, Thomas G. P., Nowotny, Boris, Geis, Maria, Jacob, Kim, Wölfl, Matthias, Trebing, Johannes, Kucka, Kirstin, Kouhestani, Dina, Gogishvili, Tea, Krenz, Bastian, Lutz, Justina, Rasche, Leo, Hönemann, Dirk, Neuweiler, Hannes, Heiby, Julia C., Bargou, Ralf C., Wajant, Harald, Einsele, Hermann, Riethmüller, Gert, Stuhler, Gernot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879491/ https://www.ncbi.nlm.nih.gov/pubmed/31772172 http://dx.doi.org/10.1038/s41467-019-13196-0 |
Ejemplares similares
-
Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
por: Geis, Maria, et al.
Publicado: (2021) -
Variant signaling topology at the cancer cell–T-cell interface induced by a two-component T-cell engager
por: Kouhestani, Dina, et al.
Publicado: (2020) -
Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
por: Kucka, Kirstin, et al.
Publicado: (2021) -
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
por: Medler, Juliane, et al.
Publicado: (2022) -
Membrane lymphotoxin-α(2)β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist
por: Kucka, Kirstin, et al.
Publicado: (2021)